UPDATED Apr 18, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
6838 | NT$53.80 | -1.6% | -9.9% | NT$7.2b | n/a | PS231.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
1271 | NT$115.50 | -3.8% | 132.4% | NT$6.9b | n/a | PE72.5x | n/a | 2.8% | Pharmaceuticals & Biotech | ||
4167 | NT$21.55 | 1.4% | 15.2% | NT$6.8b | n/a | PE227.8x | n/a | 0.5% | Pharmaceuticals & Biotech | ||
6932 | NT$16.05 | -3.6% | -40.7% | NT$6.7b | n/a | PS2491.1x | n/a | n/a | Pharmaceuticals & Biotech | ||
4126 | NT$90.40 | -0.6% | 9.2% | NT$6.6b | NT$96.00 | PE15.6x | E2.3% | 5.3% | Healthcare | ||
6762 | NT$250.00 | -1.2% | 2.5% | NT$6.5b | n/a | PE75.4x | n/a | 0.08% | Healthcare | ||
1701 | NT$21.35 | -5.7% | -17.6% | NT$6.5b | n/a | PE19.7x | n/a | 2.3% | Pharmaceuticals & Biotech | ||
4163 | NT$124.50 | 2.0% | -3.1% | NT$6.2b | n/a | PE18.2x | n/a | 2.8% | Healthcare | ||
1788 | NT$139.00 | -0.4% | -2.5% | NT$6.2b | n/a | PE17.8x | n/a | 5.0% | Healthcare | ||
1734 | NT$35.75 | -2.3% | 14.6% | NT$6.1b | n/a | PE16x | n/a | 2.8% | Pharmaceuticals & Biotech | ||
6931 | NT$106.00 | -0.9% | 114.4% | NT$5.9b | n/a | PE151x | n/a | n/a | Healthcare | ||
6569 | NT$166.00 | -3.2% | 55.9% | NT$5.6b | n/a | PE21.8x | n/a | 3.0% | Healthcare | ||
6696 | NT$70.70 | -14.9% | -62.5% | NT$5.6b | n/a | PB4.4x | n/a | n/a | Pharmaceuticals & Biotech | ||
6891 | NT$27.40 | -3.4% | -39.3% | NT$5.5b | n/a | PS13497.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
6612 | NT$139.50 | 4.9% | -12.0% | NT$5.5b | n/a | PE55.9x | n/a | 0.1% | Healthcare | ||
3176 | NT$38.80 | -4.6% | 17.4% | NT$5.4b | n/a | PS4.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
4166 | NT$23.05 | 0.2% | 3.4% | NT$5.1b | n/a | PE230.7x | n/a | n/a | Pharmaceuticals & Biotech | ||
6794 | NT$86.20 | 4.1% | 12.5% | NT$4.8b | n/a | PS195.2x | n/a | n/a | Pharmaceuticals & Biotech | ||
1752 | NT$44.15 | -4.3% | -41.6% | NT$4.6b | n/a | PE22.5x | n/a | 4.5% | Pharmaceuticals & Biotech | ||
6733 | NT$37.10 | -2.6% | -10.8% | NT$4.6b | NT$48.00 | PS41.5x | n/a | n/a | Pharmaceuticals & Biotech | ||
6747 | NT$180.00 | -4.8% | -29.7% | NT$4.4b | NT$225.95 | PE21.9x | S16.1% | 3.0% | Healthcare | ||
6580 | NT$39.35 | -0.9% | 13.6% | NT$4.3b | n/a | PS853.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
4737 | NT$68.70 | -1.4% | -8.0% | NT$4.3b | NT$80.00 | PE674.3x | n/a | 3.1% | Healthcare | ||
6634 | NT$59.50 | -6.3% | -31.7% | NT$4.2b | n/a | PB3.2x | n/a | n/a | Pharmaceuticals & Biotech |